Prospect Financial Services LLC Acurx Pharmaceuticals, Inc. Call Options Transaction History
Prospect Financial Services LLC
- $183 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACXP
# of Institutions
31Shares Held
1.42MCall Options Held
13.6KPut Options Held
4K-
Vanguard Group Inc Valley Forge, PA529KShares$359,9570.0% of portfolio
-
Geode Capital Management, LLC Boston, MA147KShares$99,6200.0% of portfolio
-
Morgan Stanley New York, NY106KShares$72,2160.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA48.4KShares$32,8940.0% of portfolio
-
State Street Corp Boston, MA43.5KShares$29,5560.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $7.86M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...